Prostamax is a short peptide bioregulator that has been studied for its potential relationship to prostate tissue, cellular activity, inflammation, and age-related changes. It has attracted interest among men looking for more proactive approaches to prostate and urinary wellness.

​

As men age, changes involving prostate size, urinary habits, inflammation, hormone balance, and tissue health can begin affecting everyday quality of life. That makes prostate health an important part of a larger healthy-aging strategy.

​

Research involving Prostamax has explored possible effects on inflammatory changes, prostate tissue structure, cellular activity, and prostate function. The available evidence remains early and is largely based on laboratory or preclinical research, so strong claims about human benefits would be premature.

​

At Shelson Integrative Health, Dr. Matthew J. Shelson looks at the whole picture, including symptoms, health history, medications, laboratory findings when appropriate, hormone health, metabolic health, lifestyle, and other relevant risk factors.

​

The goal is to help men take prostate health seriously before problems become disruptive while ensuring that appropriate medical evaluation and screening remain central to the conversation.